SCHEMBL11770064

SCHEMBL11770064

CCCCC(=O)N(CCC)CCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.61
HPGD P15428 1/20 0.61
LMNA P02545 1/20 0.54
CES1 P23141 2/20 0.48
CES2 O00748 1/20 0.48
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
CA2 P00918 1/20 0.46
MMP1 P03956 1/20 0.45
MMP2 P08253 1/20 0.45
MMP3 P08254 1/20 0.45
MMP8 P22894 1/20 0.45
SIGMAR1 Q99720 1/20 0.44
TP53 P04637 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
NCOR2 Q9Y618 1/20 0.44
CA1 P00915 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylene Chloride SCHEMBL29177161 0.93 ALDH1A1 (0.55) ALDH1A1HPGDLMNACES1CES2
SCHEMBL2477201 0.93 ALDH1A1 (0.59) ALDH1A1HPGDLMNACES1CES2
SCHEMBL3310896 0.92 ALDH1A1 (0.64) ALDH1A1HPGDLMNACES1CES2
SCHEMBL19404635 0.92 ALDH1A1 (0.64) ALDH1A1HPGDLMNACA12CA9
SCHEMBL30516910 0.91 ALDH1A1 (0.53) ALDH1A1HPGDLMNACES1CES2
SCHEMBL782029 0.91 ALDH1A1 (0.57) ALDH1A1HPGDLMNACES1CES2
SCHEMBL2059032 0.91 ALDH1A1 (0.57) ALDH1A1HPGDLMNACES1CES2
SCHEMBL9631729 0.91 ALDH1A1 (0.57) ALDH1A1HPGDLMNACES1CES2
SCHEMBL9631084 0.91 ALDH1A1 (0.57) ALDH1A1HPGDLMNACES1CES2
SCHEMBL9631671 0.91 ALDH1A1 (0.57) ALDH1A1HPGDLMNACES1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114736115-A Method for extracting and separating succinic acid and succinate in aqueous solution 哈尔滨工业大学(威海) 2022-07-12 CN claimed
US-3988472-A ANTICONVULSANTS, TRANQUILIZERS LABAZ (FR) 1976-10-26 US claimed
US-12630731-B2 Non-aqueous ink composition DNP FINE CHEMICALS CO., LTD. (JP) 2026-05-19 US disclosed
US-20260125570-A1 NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS DNP FINE CHEMICALS CO., LTD. (JP) 2026-05-07 US disclosed
US-12590216-B2 Water-based ink and ink set including same DNP FINE CHEMICALS CO., LTD. (JP) 2026-03-31 US disclosed
US-12522744-B2 Ink set DNP FINE CHEMICALS CO., LTD. (JP) 2026-01-13 US disclosed
US-20250368766-A1 RESIN, RESIN DISPERSION, AND RESIN COMPOSITION DNP FINE CHEMICALS CO., LTD. (JP) 2025-12-04 US disclosed
EP-4617333-A1 NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS DNP Fine Chemicals Co., Ltd. (JP) 2025-09-17 EP disclosed
US-12398444-B2 Diglycolamide derivatives for separation and recovery of rare earth elements from aqueous solutions UT-BATTELLE, LLC (US) 2025-08-26 US disclosed
US-20250236749-A1 NON-AQUEOUS INK COMPOSITION DNP FINE CHEMICALS CO., LTD. (JP) 2025-07-24 US disclosed
EP-4549474-A1 RESIN, RESIN DISPERSION, AND RESIN COMPOSITION DNP Fine Chemicals Co., Ltd. (JP) 2025-05-07 EP disclosed
US-20220002840-A1 METHODS FOR SEPARATION AND RECOVERY OF RARE EARTH ELEMENTS FROM AQUEOUS SOLUTIONS USING DIGLYCOLAMIDE DERIVATIVES BATTELLE ENERGY ALLIANCE, LLC 2022-01-06 US disclosed
US-20220002229-A1 DIGLYCOLAMIDE DERIVATIVES FOR SEPARATION AND RECOVERY OF RARE EARTH ELEMENTS FROM AQUEOUS SOLUTIONS UT-BATTELLE, LLC 2022-01-06 US disclosed
US-11040296-B2 Lipophilic diglycolamide compounds for extraction of rare earth metals from aqueous solutions UT-BATTELLE, LLC (US) 2021-06-22 US disclosed
US-20190344198-A1 LIPOPHILIC DIGLYCOLAMIDE COMPOUNDS FOR EXTRACTION OF RARE EARTH METALS FROM AQUEOUS SOLUTIONS UT-BATTELLE, LLC 2019-11-14 US disclosed
WO-2017162536-A1 VORTIOXETINE PRODRUGS H. LUNDBECK A/S (DK) 2017-09-28 WO disclosed
WO-2007142986-A2 AMINOTHIAZOLE DERIVATIVES AND THEIR USES AS ANTIBACTERIAL AGENTS NOVARTIS AG (CH) 2007-12-13 WO disclosed
US-3988472-A ANTICONVULSANTS, TRANQUILIZERS LABAZ (FR) 1976-10-26 US disclosed
US-3988472-A ANTICONVULSANTS, TRANQUILIZERS LABAZ (FR) 1976-10-26 US disclosed
US-3958011-A ADMINISTERING LABAZ (FR) 1976-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630731-B2 Non-aqueous ink composition EXOSC10, RPP30, RPS20 ALDH1A1 1893/4885HPGD 3620/4885LMNA 3836/4885
US-11040296-B2 Lipophilic diglycolamide compounds for extraction of rare earth metals from aqueous solutions GBA1, GLA, GAA ALDH1A1 3244/4885HPGD 1654/4885LMNA 1172/4885
US-20190344198-A1 LIPOPHILIC DIGLYCOLAMIDE COMPOUNDS FOR EXTRACTION OF RARE EARTH METALS FROM AQUEOUS SOLUTIONS GBA1, GLA, GAA ALDH1A1 3244/4885HPGD 1654/4885LMNA 1172/4885
US-12590216-B2 Water-based ink and ink set including same TYR, ITGB3, ARCN1 ALDH1A1 1130/4885HPGD 2233/4885LMNA 2340/4885
US-12398444-B2 Diglycolamide derivatives for separation and recovery of rare earth elements from aqueous solutions GNE, GALE, ARGLU1 ALDH1A1 3536/4885HPGD 3236/4885LMNA 3366/4885
US-20220002229-A1 DIGLYCOLAMIDE DERIVATIVES FOR SEPARATION AND RECOVERY OF RARE EARTH ELEMENTS FROM AQUEOUS SOLUTIONS GNE, GALE, ARGLU1 ALDH1A1 3536/4885HPGD 3236/4885LMNA 3366/4885
US-20260125570-A1 NONAQUEOUS INK COMPOSITION, RECORDING METHOD, METHOD FOR PRODUCING RECORDED MATERIAL, INK SET, RECORDED MATERIAL, AND INKJET RECORDING APPARATUS BMI1, IK, PRDM9 ALDH1A1 333/4885HPGD 4064/4885LMNA 3395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.